Answers are grounded in this paper and cite their sources.
Gastrointestinal metastasis from breast carcinoma is uncommon and can closely mimic primary gastrointestinal malignancy. Its site-specific clinicopathological features remain incompletely characterised, particularly in cases with atypical receptor profiles or limited molecular annotation. We performed an individual patient-level pooled analysis of published cases of breast carcinoma metastasis to the gastrointestinal tract, supplemented by a molecularly characterised BRCA1-associated index case. Cases were analysed descriptively according to metastatic site, clinical presentation, histopathology, immunophenotype, receptor status, treatment, outcome, and available molecular findings. Twenty published cases were integrated with the index case, yielding 21 patients. Small-bowel involvement was the most frequent metastatic pattern (8/21, 38.1%), followed by gastric/diffuse gastrointestinal involvement (5/21, 23.8%) and colonic and rectal involvement (4/21, 19.0% each). Invasive lobular carcinoma predominated overall, and six cases were classified as TNBC-associated. Clinical, endoscopic, and radiologic findings were nonspecific and frequently mimicked primary gastrointestinal malignancy. The index case demonstrated ileal metastasis 17 years after primary TNBC, with supportive immunophenotypic and molecular findings including a pathogenic germline BRCA1 variant and a somatic TP53 alteration. Breast carcinoma metastasis to the gastrointestinal tract should remain in the differential diagnosis of atypical gastrointestinal lesions after breast cancer, even after a long disease-free interval. Integrated clinicopathological, immunophenotypic, and selected molecular assessment may support tumour-origin assignment.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: